TAZEMETOSTAT, IMFINZI 50 mg/mL concentrate for solution for infusion.
IB 2019-04
Phase 2 small_molecule active
Quick answer
TAZEMETOSTAT, IMFINZI 50 mg/mL concentrate for solution for infusion. for Adult participants with metastatic or unresectable locally advanced solid tumors. is a Phase 2 program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Adult participants with metastatic or unresectable locally advanced solid tumors.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active